U.S. DNA Manufacturing Market Accelerates Amid Gene Therapy Boom

added blog Other

2025-07-01 06:25:41 -

Executive Summary The U.S. DNA manufacturing market is entering a high-growth phase, driven by the explosive rise of gene and cell therapies, synthetic biology, and the increasing use of DNA in vaccines, diagnostics, and therapeutics. Valued at USD 2.22 billion in 2024, the market is projected to grow at a CAGR of 18.14%, reaching USD 11.72...

0 Comments 0 Shares 102 Views 0 Reviews